Teva Pharmaceutical Industries (TEVA) Stock Forecast, Price Target & Predictions
TEVA Stock Forecast
Teva Pharmaceutical Industries stock forecast is as follows: an average price target of $20.00 (represents a 16.82% upside from TEVA’s last price of $17.12) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
TEVA Price Target
TEVA Analyst Ratings
Buy
Teva Pharmaceutical Industries Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 23, 2024 | Balaji Prasad | Barclays | - | - | 36.02% | 46.03% |
Oct 01, 2024 | Jason Gerberry | Bank of America Securities | - | - | 23.94% | 28.50% |
Sep 03, 2024 | Ashwani Verma | UBS | - | - | 41.11% | 51.87% |
Aug 28, 2024 | David Amsellem | Piper Sandler | - | - | 23.56% | 34.35% |
Aug 01, 2024 | Balaji Prasad | Barclays | - | - | 26.22% | 28.50% |
Jul 10, 2024 | Jasper Hellweg | Argus Research | - | - | 26.50% | 16.82% |
Jul 10, 2024 | Ashwani Verma | UBS | - | - | 51.80% | 40.19% |
Jun 05, 2024 | Balaji Prasad | Barclays | - | - | 26.28% | 22.66% |
May 23, 2024 | Balaji Prasad | Barclays | - | - | 19.33% | 16.82% |
May 13, 2024 | David Amsellem | Piper Sandler | - | - | 18.38% | 16.82% |
10
Teva Pharmaceutical Industries Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 4 | 12 |
Avg Price Target | - | $24.00 | $21.33 |
Last Closing Price | $17.12 | $17.12 | $17.12 |
Upside/Downside | -100.00% | 40.19% | 24.59% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 23, 2024 | Barclays | Overweight | Overweight | Hold |
Oct 01, 2024 | Bank of America Securities | Buy | Buy | Hold |
Sep 09, 2024 | Jefferies | Buy | Buy | Hold |
Sep 03, 2024 | UBS | Buy | Buy | Hold |
Aug 28, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Aug 01, 2024 | Barclays | Overweight | Overweight | Hold |
Jul 10, 2024 | UBS | Buy | Buy | Hold |
Jun 27, 2024 | Jefferies | Buy | Buy | Hold |
Jun 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jun 05, 2024 | Barclays | Overweight | Overweight | Hold |
10
Teva Pharmaceutical Industries Financial Forecast
Teva Pharmaceutical Industries Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $4.46B | $3.85B | $3.88B | $3.66B | $3.88B | $3.60B | $3.79B | $3.66B | $4.10B | $3.89B | $3.91B | $3.98B | $4.45B | $3.98B | $3.87B | $4.36B | $3.99B | $4.26B | $4.34B | $4.29B | $5.07B | $5.63B |
Avg Forecast | $4.29B | $4.47B | $4.26B | $3.94B | $4.10B | $4.14B | $4.06B | $3.73B | $4.03B | $3.73B | $3.71B | $3.62B | $3.89B | $3.84B | $3.78B | $3.74B | $4.28B | $4.03B | $4.02B | $4.02B | $4.37B | $4.07B | $3.93B | $4.15B | $4.35B | $4.24B | $4.25B | $4.38B | $3.61B | $5.47B |
High Forecast | $4.38B | $4.57B | $4.35B | $4.02B | $4.29B | $4.14B | $4.06B | $3.73B | $4.08B | $3.81B | $3.80B | $3.70B | $3.97B | $3.84B | $3.78B | $3.74B | $4.28B | $4.03B | $4.02B | $4.02B | $4.37B | $4.07B | $3.93B | $4.15B | $4.35B | $4.24B | $4.25B | $4.38B | $4.33B | $6.56B |
Low Forecast | $4.21B | $4.39B | $4.18B | $3.88B | $3.97B | $4.14B | $4.06B | $3.73B | $3.93B | $3.59B | $3.65B | $3.55B | $3.82B | $3.84B | $3.78B | $3.74B | $4.28B | $4.03B | $4.02B | $4.02B | $4.37B | $4.07B | $3.93B | $4.15B | $4.35B | $4.24B | $4.25B | $4.38B | $2.89B | $4.37B |
# Analysts | 1 | 1 | 1 | 1 | 5 | 4 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 20 |
Surprise % | - | - | - | - | - | - | - | - | 1.11% | 1.03% | 1.04% | 1.01% | 1.00% | 0.94% | 1.00% | 0.98% | 0.96% | 0.96% | 0.97% | 0.99% | 1.02% | 0.98% | 0.98% | 1.05% | 0.92% | 1.01% | 1.02% | 0.98% | 1.40% | 1.03% |
Forecast
Teva Pharmaceutical Industries EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 5 | 4 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 20 |
EBITDA | - | - | - | - | - | - | - | - | $755.00M | $1.04B | $979.00M | $813.00M | $1.05B | $993.00M | $1.05B | $1.01B | $1.09B | $1.04B | $1.09B | $1.13B | $1.12B | $1.08B | $1.07B | $1.33B | $1.12B | $1.11B | $1.13B | $1.08B | $1.62B | $1.63B |
Avg Forecast | $379.85M | $395.50M | $376.83M | $349.18M | $362.50M | $366.43M | $358.96M | $390.83M | $356.44M | $330.41M | $328.79M | $355.30M | $231.28M | $995.73M | $978.91M | $323.00M | $1.11B | $1.04B | $1.04B | $750.42M | $1.13B | $1.06B | $1.02B | $450.61M | $1.13B | $1.10B | $1.10B | $545.52M | $1.28B | $1.35B |
High Forecast | $388.15M | $404.14M | $385.07M | $355.68M | $379.84M | $366.80M | $358.96M | $469.00M | $360.92M | $337.41M | $335.98M | $426.36M | $277.54M | $995.73M | $978.91M | $387.60M | $1.11B | $1.04B | $1.04B | $900.51M | $1.13B | $1.06B | $1.02B | $540.73M | $1.13B | $1.10B | $1.10B | $654.62M | $1.53B | $1.61B |
Low Forecast | $372.80M | $388.16M | $369.85M | $343.61M | $351.22M | $366.07M | $358.96M | $312.66M | $347.46M | $317.38M | $322.69M | $284.24M | $185.03M | $995.73M | $978.91M | $258.40M | $1.11B | $1.04B | $1.04B | $600.34M | $1.13B | $1.06B | $1.02B | $360.49M | $1.13B | $1.10B | $1.10B | $436.41M | $1.02B | $1.08B |
Surprise % | - | - | - | - | - | - | - | - | 2.12% | 3.16% | 2.98% | 2.29% | 4.54% | 1.00% | 1.07% | 3.13% | 0.98% | 0.99% | 1.04% | 1.51% | 0.98% | 1.03% | 1.05% | 2.96% | 0.99% | 1.01% | 1.02% | 1.99% | 1.27% | 1.21% |
Forecast
Teva Pharmaceutical Industries Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 5 | 4 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 20 |
Net Income | - | - | - | - | - | - | - | - | $461.00M | $80.00M | $-863.00M | $-239.00M | $-1.25B | $56.00M | $-260.00M | $-973.00M | $-151.00M | $292.00M | $207.00M | $77.00M | $150.00M | $-4.47B | $140.00M | $69.00M | $80.00M | $-303.00M | $-671.00M | $-105.00M | $1.12B | $645.00M |
Avg Forecast | $855.04M | $843.71M | $745.29M | $606.95M | $784.49M | $749.20M | $625.42M | $582.14M | $869.59M | $688.69M | $595.09M | $631.10M | $-164.91M | $697.77M | $658.68M | $622.19M | $831.43M | $730.32M | $671.12M | $71.78M | $711.83M | $659.54M | $595.65M | $49.12M | $686.82M | $670.76M | $647.75M | $-101.38M | $735.52M | $626.21M |
High Forecast | $879.32M | $867.67M | $766.45M | $631.23M | $829.97M | $752.18M | $643.18M | $582.25M | $985.53M | $767.72M | $611.99M | $649.03M | $-131.92M | $697.77M | $658.68M | $622.19M | $831.43M | $730.32M | $671.12M | $86.14M | $711.83M | $659.54M | $595.65M | $58.94M | $686.82M | $670.76M | $647.75M | $-81.10M | $882.63M | $751.46M |
Low Forecast | $834.43M | $823.37M | $727.32M | $582.67M | $761.75M | $746.22M | $610.34M | $582.02M | $834.81M | $632.25M | $580.74M | $615.89M | $-197.89M | $697.77M | $658.68M | $622.19M | $831.43M | $730.32M | $671.12M | $57.42M | $711.83M | $659.54M | $595.65M | $39.29M | $686.82M | $670.76M | $647.75M | $-121.66M | $588.42M | $500.97M |
Surprise % | - | - | - | - | - | - | - | - | 0.53% | 0.12% | -1.45% | -0.38% | 7.60% | 0.08% | -0.39% | -1.56% | -0.18% | 0.40% | 0.31% | 1.07% | 0.21% | -6.79% | 0.24% | 1.40% | 0.12% | -0.45% | -1.04% | 1.04% | 1.52% | 1.03% |
Forecast
Teva Pharmaceutical Industries SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 5 | 4 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 20 |
SG&A | - | - | - | - | - | - | - | - | $901.00M | $844.00M | $910.00M | $842.00M | $838.00M | $822.00M | $907.00M | $880.00M | $908.00M | $888.00M | $857.00M | $875.00M | $1.01B | $884.00M | $861.00M | $917.00M | $1.02B | $880.00M | $962.00M | $940.00M | $1.10B | $1.21B |
Avg Forecast | $960.80M | $1.00B | $953.18M | $883.23M | $916.91M | $926.87M | $907.97M | $835.53M | $901.58M | $835.75M | $831.66M | $810.43M | $941.73M | $859.81M | $845.28M | $836.90M | $958.55M | $902.00M | $899.54M | $815.68M | $978.68M | $911.50M | $880.37M | $652.78M | $974.25M | $948.27M | $950.92M | $907.59M | $722.39M | $1.17B |
High Forecast | $981.79M | $1.02B | $974.00M | $899.67M | $960.78M | $927.78M | $907.97M | $835.53M | $912.93M | $853.46M | $849.83M | $828.13M | $1.13B | $859.81M | $845.28M | $836.90M | $958.55M | $902.00M | $899.54M | $978.81M | $978.68M | $911.50M | $880.37M | $783.34M | $974.25M | $948.27M | $950.92M | $1.09B | $866.87M | $1.41B |
Low Forecast | $942.98M | $981.83M | $935.50M | $869.13M | $888.40M | $925.95M | $907.97M | $835.53M | $878.87M | $802.79M | $816.23M | $795.40M | $753.38M | $859.81M | $845.28M | $836.90M | $958.55M | $902.00M | $899.54M | $652.54M | $978.68M | $911.50M | $880.37M | $522.22M | $974.25M | $948.27M | $950.92M | $726.07M | $577.91M | $937.48M |
Surprise % | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.09% | 1.04% | 0.89% | 0.96% | 1.07% | 1.05% | 0.95% | 0.98% | 0.95% | 1.07% | 1.03% | 0.97% | 0.98% | 1.40% | 1.05% | 0.93% | 1.01% | 1.04% | 1.52% | 1.03% |
Forecast
Teva Pharmaceutical Industries EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 5 | 4 | 3 | 3 | 6 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 16 | 8 | 11 | 7 | 11 | 7 | 7 | 17 | 20 |
EPS | - | - | - | - | - | - | - | - | $0.41 | $0.07 | $-0.77 | $-0.21 | $-1.13 | $0.05 | $-0.23 | $-0.88 | $-0.14 | $0.26 | $0.19 | $0.07 | $0.14 | $-4.08 | $0.13 | $0.06 | $0.07 | $-0.28 | $-0.61 | $-0.09 | $1.04 | $0.57 |
Avg Forecast | $0.75 | $0.74 | $0.66 | $0.54 | $0.69 | $0.66 | $0.55 | $0.51 | $0.77 | $0.61 | $0.53 | $0.56 | $0.72 | $0.62 | $0.58 | $0.55 | $0.73 | $0.64 | $0.59 | $0.59 | $0.63 | $0.58 | $0.53 | $0.59 | $0.61 | $0.59 | $0.57 | $0.58 | $0.44 | $1.00 |
High Forecast | $0.78 | $0.77 | $0.68 | $0.56 | $0.73 | $0.66 | $0.57 | $0.51 | $0.87 | $0.68 | $0.54 | $0.57 | $0.74 | $0.62 | $0.58 | $0.55 | $0.73 | $0.64 | $0.59 | $0.59 | $0.63 | $0.58 | $0.53 | $0.59 | $0.61 | $0.59 | $0.57 | $0.58 | $0.53 | $1.20 |
Low Forecast | $0.74 | $0.73 | $0.64 | $0.51 | $0.67 | $0.66 | $0.54 | $0.51 | $0.74 | $0.56 | $0.51 | $0.54 | $0.70 | $0.62 | $0.58 | $0.55 | $0.73 | $0.64 | $0.59 | $0.59 | $0.63 | $0.58 | $0.53 | $0.59 | $0.61 | $0.59 | $0.57 | $0.58 | $0.35 | $0.80 |
Surprise % | - | - | - | - | - | - | - | - | 0.53% | 0.12% | -1.47% | -0.38% | -1.58% | 0.08% | -0.40% | -1.60% | -0.19% | 0.40% | 0.32% | 0.12% | 0.22% | -7.01% | 0.25% | 0.10% | 0.12% | -0.47% | -1.07% | -0.15% | 2.36% | 0.57% |
Forecast
Teva Pharmaceutical Industries Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TLRY | Tilray Brands | - | - | 453.73% | Hold |
CGC | Canopy Growth | - | - | 271.03% | Hold |
SNDL | SNDL | - | - | 99.49% | Hold |
ELAN | Elanco Animal Health | - | - | 98.35% | Buy |
CRON | Cronos Group | - | - | 64.90% | Hold |
ACB | Aurora Cannabis | - | - | 36.41% | Hold |
ZTS | Zoetis | - | - | 28.68% | Buy |
BHC | Bausch Health Companies | - | - | 25.47% | Hold |
CTLT | Catalent | - | - | 21.76% | Hold |
TEVA | Teva Pharmaceutical Industries | - | - | 16.82% | Buy |
VTRS | Viatris | - | - | 2.84% | Hold |
HLN | Haleon | - | - | -5.18% | Buy |
LFCR | Lifecore Biomedical | - | - | -11.08% | Buy |